Eto A, Shiki A, Chikaura Y, Oka T, Nakano N I
Chemo-Sero-Therapeutic Research Institute (KAKET-SUKEN), Kumamoto, Japan.
Clin Chem. 1995 Jun;41(6 Pt 1):872-80.
We have developed a new multienzyme control serum, Seraclear-HE, which was designed to function not only as an accuracy and precision control serum but also as an intermethod calibrator for unifying interlaboratory clinical enzyme data in terms of reference method values. Seraclear-HE contains as analytes the following enzymes of human origin only: aspartate aminotransferase (AST, EC 2.6.1.1) and lactate dehydrogenase (LD, EC 1.1.1.27) from erythrocytes; alanine aminotransferase (ALT, EC 2.6.1.2) from a hepatoma cell line; alkaline phosphatase (ALP, EC 3.1.3.1) from an amnion cell line; creatine kinase (CK, EC 2.7.3.2) from an embryo kidney cell line; gamma-glutamyltransferase (GGT, EC 2.3.2.2) from a macrophage cell line; and amylase (AMY, EC 3.2.1.1) from urine and saliva. The seven partly purified enzymes were lyophilized in partially delipidated human serum containing sucrose (50 g/L), pyridoxal 5'-phosphate (30 mmol/L), and other stabilizers. The material is stable for at least 2 years at temperatures < or = 10 degrees C. For two concentrations of this preparation, reference method values (mainly International Federation of Clinical Chemistry and Japan Society of Clinical Chemistry) obtained at both 30 degrees C and 37 degrees C are assigned.
我们研发了一种新型多酶质控血清,即Seraclear-HE,其设计目的不仅是作为准确度和精密度控制血清,还作为一种方法间校准物,以便根据参考方法值统一实验室间的临床酶数据。Seraclear-HE仅包含以下源自人类的酶作为分析物:来自红细胞的天冬氨酸氨基转移酶(AST,EC 2.6.1.1)和乳酸脱氢酶(LD,EC 1.1.1.27);来自肝癌细胞系的丙氨酸氨基转移酶(ALT,EC 2.6.1.2);来自羊膜细胞系的碱性磷酸酶(ALP,EC 3.1.3.1);来自胚胎肾细胞系的肌酸激酶(CK,EC 2.7.3.2);来自巨噬细胞系的γ-谷氨酰转移酶(GGT,EC 2.3.2.2);以及来自尿液和唾液的淀粉酶(AMY,EC 3.2.1.1)。这七种部分纯化的酶在含有蔗糖(50 g/L)、磷酸吡哆醛(30 mmol/L)和其他稳定剂的部分脱脂人血清中冻干。该物质在温度≤10℃时至少稳定2年。对于该制剂的两种浓度,给出了在30℃和37℃时获得的参考方法值(主要是国际临床化学联合会和日本临床化学学会的)。